Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer